InvestorsHub Logo
Followers 10
Posts 504
Boards Moderated 0
Alias Born 04/20/2016

Re: None

Monday, 04/05/2021 12:05:18 PM

Monday, April 05, 2021 12:05:18 PM

Post# of 233756
More anecdotal evidence as to the effectiveness of Leronlimab in treating Covid that the US FDA will likely ignore.

The big question for investors is whether the Philippines FDA, and other global FDA's, will issue EUA's given that there is little risk in doing so as Leronlimab has not resulted in any serious adverse events in the treatment of over 1,000 patients for Covid, cancer, and HIV.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News